AIM Rule 26
Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 global pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail.
With more than 2,500 employees the Group is active in Ireland, UK, Benelux., Nordics and USA
Country of Incorporation and Main Country of Operation
Uniphar Group plc is incorporated and headquartered in Ireland (Company registration number: 224324).
The Group’s main operations are from its facilities in:
4045 Kingswood Road, Citywest Business Park, County Dublin, Ireland.
The rights of shareholders in an Irish incorporated company may be different from the rights of shareholders in a UK incorporated company.
Nominated Adviser and Other Key Advisers
Please click on the link for information of the Company’s Nominated Adviser and other key advisers, including contact details, which will be investor contacts.
Details of Any Other Exchanges or Trading Platforms
The company's shares are listed on the AIM and Euronext Growth markets of the London Stock Exchange and Euronext Dublin, respectively.
Number of Securities in Issue
Ordinary Shares in issue: 273,015,254
Significant Shareholders information:
|Ordinary Shares held
|Allianz Global Investors
|Power Corporation of Canada
(1) Including Ordinary Shares issued under the 2018 LTIP
Details of Any Restrictions on the Transfer of Securities
There are no restrictions on the transfer of securities.
Uniphar plc is a public limited Company incorporated in Ireland and its ordinary shares are admitted to trading on the Euronext Growth Market of Euronext Dublin and AIM of the London Stock Exchange. As a result, the Company is subject to the provisions of the Irish Takeover Rules. The Irish Takeover Rules regulate acquisitions of the Company's securities. Irish Takeover rules are defined as "The Irish Takeover Panel Act 1997, Takeover Rules, 2022 (as amended)